The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.941%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
ARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PRELIMINARY RESULTS

12 Sep 2011 07:00

RNS Number : 9714N
Arcontech Group PLC
12 September 2011
 



ARCONTECH GROUP PLC

 

("Arcontech" or the "Company")

 

 

PRELIMINARY RESULTS FOR THE YEAR ENDED 30 JUNE 2011

 

Arcontech Group PLC (AIM: ARC), providers of products and services for real-time financial market data processing and trading, reports its preliminary results for the year ended 30 June 2010.

 

 

Chairman's Statement

 

I am pleased to report progress in the year ended 30 June 2011, with turnover increasing to £1,287,409 (2010: £1,068,776) and operating loss reduced to £817,855 (2010: £918,754). We did not, however, quite achieve the level of sales we had hoped for, due primarily to the increasingly long sales cycles of the major investment banks. The demand for AXE, the CfD and spread betting solution was disappointing and we have taken the decision to concentrate sales resource on our CityVision Vendor Contribution, including Excelerator, products for which the opportunities are proving exciting.

 

Where possible we enter into recurring annual licence fee contracts, typically for a minimum of three years duration. It is our aim to increase our annual recurring revenues each year. As at 30 June 2011 the contracted future annual recurring revenues of the business were £1,538,216 (2010: £1,081,668), an increase of 42%. This level of annual recurring revenues, now covers approximately 73% (2010: 54%) of our expected cost base. Our level of recurring revenues now provide a sound base upon which to grow our business.

 

Whilst we continued to develop the AXE product, earlier in the year a lack of customer interest caused a change in focus to increasing the functionality, scope and capability, of our CityVision products. As in previous years, we have continued to write off all product development costs as they are incurred. The product developments completed during the year have been heavily influenced by prospective customers and have improved our competitive position significantly. We have invested notable sums, relative to our size to integrate our products with Bloomberg systems, which we believe will provide significant growth opportunities. We will continue to invest in product development, but in the future it is expected that this will increasingly be as a result of specific customer requirements. As our spend on pure product development declines we expect to increase resources in technical support, account management and sales and marketing. These additional costs, however, will not be incurred until increased revenues are secured.

 

Financing

 

As at 30 June 2011 Arcontech had cash balances of £841,204 (2010: £1,586,376). We believe, on the basis of current projections and expectations that the Group has sufficient resources to see it through to cash breakeven at the trading level and beyond.

 

Management and staff

 

Our management and staff are our key resource. They have continued to work with determination and dedication and I thank them for their continued support. As our customer base increases, particularly in overseas markets, the demands on our staff will undoubtedly increase. I am confident that they will continue to perform to the high standards that they have set in previous years.

 

Outlook

 

With the CityVision product developments completed since the year-end, we believe we are in a positive position to start to realise the sales opportunities identified previously for those products. Sales made since the year end for new products with international financial institutions, reinforce our belief that there is strong demand for our products in the market. It does, however, remain true that the sales cycles continue to be long and invariably involve pilot studies. Consequently it remains difficult to predict with any degree of certainty the precise timing of future sales. Accordingly we are maintaining a tight control over expenditure whilst continuing to develop opportunities for the business.

 

Richard Last

Chairman

Chief Executive's Review

 

Significant progress has been made this year in terms of product development, pipeline improvement and restructuring to address the demands of increasingly complex sales in a market which remains difficult. Whilst bottom-line financial performance is disappointing, due to the protracted sales cycle common in investment banking, there are strong signs that our efforts will pay off and I remain optimistic over forward revenues.

 

Engagement with several tier one international banks has lead to further refinement of the CityVision product suite for controlled, low latency market data distribution and systems integration. Close working with data vendor systems including those from Thomson Reuters and Bloomberg has lead to new product development with considerable market potential. Some significant sales have already been achieved, with a promising and growing prospect list.

 

We have seen less demand for AXE, our retail trading system product and have decided to restructure to concentrate our resources on CityVision, our sell-side market data technology where we believe there are greater opportunities.

 

Tight cost-control has remained a primary objective for many of our major target customers. Whilst this often reduces the immediate budget for our innovative solutions, it nonetheless provides opportunities for Arcontech as part of a vendor/technology replacement strategy. We have produced new products and re-engineered existing ones to provide compelling value propositions which are gaining considerable traction.

 

The main achievements and themes of the year have been:

 

·; Greatly increased pre-sales activity, including global evaluations

·; Pipeline progression leading to significant recently announced contracts

·; Continued focus on the major international investment banks

·; Expansion of global capability to provide follow-the-sun support in key regions

·; Further product development based on feedback from clients and prospects

 

Work this year has resulted in new contracts in excess of £1.4 million over three years, which will affect our future bottom line. These include further sales of our Excelerator real-time desktop product, displacement of competitive incumbent vendor contribution systems and, perhaps most significantly, green-field deployments for our innovative 'gateway' technology for cross-connectivity between the major data vendors such as Thomson Reuters and Bloomberg. This technology is at the heart of further opportunities we are progressing and we are excited about developments in this area.

 

The value of contracts achieved and in discussion continues to increase, with contractual recurring revenues as we enter the new financial year of £1,538,216, covering approximately 73% of our expenditure. Further product evaluations are underway and seem on track to yield meaningful additional revenue in the short to medium term.

 

Overall, despite the figures for the year, sales progress is positive and the level of interest in our next generation of products bodes well for the future. I would like to thank our staff, clients and prospects for their continued help and support and look forward to joint successes in the coming year.

 

Andrew Miller

Chief Executive

 

Enquiries, please contact:

 

Andrew Miller (Chief Executive)

Arcontech Group PLC

020 7256 2300

Richard Last (Chairman and Non-Executive Director)

Arcontech Group PLC

01608 683 108

Shane Gallwey / Edward Hutton

Northland Capital Partners Limited

020 7796 8800

 

 

 

 

Group Income Statement

 

For the year ended 30 June 2011

 

 

 

 

2011

 

2010

 

 

 

£

 

£

 

 

 

 

 

 

 

Revenue

 

1,287,409

 

1,068,776

 

Distribution costs

 

(16,428

)

(25,242

)

Administrative costs

 

(2,088,836

)

(1,962,288

)

Operating loss

 

(817,855

)

(918,754

)

Finance income

 

13,134

 

5,681

 

Loss before taxation

 

(804,721

)

(913,073

)

Taxation

 

132,683

 

-

 

Loss for the year after tax

 

(672,038

)

(913,073

)

Total comprehensive income

 

(672,038

)

(913,073

)

Loss per share (basic and diluted)

 

(0.04

) p 

(0.07

) p 

 

All of the results relate to continuing operations.

 

Statement of Changes in Equity

 

 

For the year ended 30 June 2011

 

Group:

 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Shares to be issued

Total

equity

 

£

£

£

£

£

£

Balance at 1 July 2009

736,443

8,516,940

108,742

(7,387,674)

200,606

2,175,057

Loss for the year

-

-

-

(913,073)

-

(913,073)

Total comprehensive income for the year

for the year

 

-

 

-

 

-

 

(913,073)

 

-

 

(913,073)

Share-based payments

 

-

 

-

 

34,555

-

 

-

 

34,555

Issue of shares

 

794,872

911,229

-

-

(200,606)

1,505,495

Balance at 30 June 2010

1,531,315

9,428,169

143,297

(8,300,747)

-

2,802,034

Loss for the year

-

-

-

(672,038)

-

(672,038)

Total comprehensive income for the year

 

 

-

 

-

 

-

 

(672,038)

 

-

 

(672,038)

Share-based payments

 

-

 

-

 

2,241

 

-

 

-

 

2,241

Balance at 30 June 2011

1,531,315

9,428,169

145,538

(8,972,785)

-

2,132,237

 

 

Company:

 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Shares to be issued

Total

equity

 

£

£

£

£

£

£

Balance at 1 July 2009

736,443

8,516,940

108,742

(7,284,443)

200,606

2,278,288

Loss for the year

-

-

-

(162,935)

-

(162,935)

Total comprehensive income for the year

 

-

-

-

(162,935)

-

(162,935)

Share-based payments

 

-

 

-

 

34,555

 

-

 

-

 

34,555

Issue of shares

794,872

911,229

-

-

(200,606)

1,505,495

Balance at 30 June 2010

1,531,315

9,428,169

143,297

(7,447,378)

-

3,655,403

Loss for the year

-

-

-

(82,460)

-

(82,460)

Total comprehensive income for the year

 

-

-

-

(82,460)

-

(82,460)

Share-based payments

 

-

 

-

 

2,241

 

-

-

 

2,241

Balance at 30 June 2011

1,531,315

9,428,169

145,538

(7,529,838)

-

3,575,184

 

 

 

 

Balance Sheets

 

As at 30 June 2011

 

 

 

Group2011£

 

Group2010£

 

Company2011£

 

Company2010

£

 

 

 

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

 

 

Goodwill

 

1,715,153

 

1,715,153

 

-

 

-

 

Property, plant and equipment

 

37,426

 

46,597

 

-

 

-

 

Investments in subsidiaries

 

-

 

-

 

2,017,373

 

2,017,373

 

Total non-current assets

 

1,752,579

 

1,761,750

 

2,017,373

 

2,017,373

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Trade and other receivables

 

366,425

 

213,921

 

1,450,431

 

1,257,236

 

Cash and cash equivalents

 

841,204

 

1,586,376

 

471,172

 

859,378

 

Total current assets

 

1,207,629

 

1,800,297

 

1,921,603

 

2,116,614

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

Trade and other payables

(827,971

)

(760,013

)

(363,792

)

(478,584

)

Total current liabilities

(827,971

)

(760,013

)

(363,792

)

(478,584

)

 

 

 

 

 

 

 

 

Net current assets

379,658

 

1,040,284

 

1,557,811

 

1,638,030

 

 

 

 

 

 

 

 

 

Net assets

 

2,132,237

 

2,802,034

 

3,575,184

 

3,655,403

 

 

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

Called up share capital

 

1,531,315

 

1,531,315

 

1,531,315

 

1,531,315

 

Share premium account

 

9,428,169

 

9,428,169

 

9,428,169

 

9,428,169

 

Share option reserve

 

145,538

 

143,297

 

145,538

 

143,297

 

Retained earnings

 

(8,972,785

)

(8,300,747

)

(7,529,838

)

(7,447,378

)

 

 

2,132,237

 

2,802,034

 

3,575,184

 

3,655,403

 

 

 

Group Cash Flow Statement

 

 

For the year ended 30 June 2011

 

 

 

2011

 

2010

 

 

 

£

 

£

 

 

 

 

 

 

 

Net cash used in operating activities

 

(747,493

)

(343,682

)

Investing activities

 

 

 

 

 

Interest received

 

13,134

 

5,681

 

Acquisition of subsidiary, net of cash acquired

 

-

 

(1

)

Purchases of plant and equipment

 

(11,214

)

(8,232

)

Disposal of plant and equipment

 

401

 

405

 

Net cash received/(used) in investing activities

 

2,321

 

(2,147

)

Financing activities

 

 

 

 

 

Proceeds on issue of shares

 

-

 

1,553,270

 

Expenses paid in connection with share issues

 

-

 

(47,775

)

Net cash generated from financing activities

 

-

 

1,505,495

 

Net (decrease)/increase in cash and cash equivalents

 

(745,172

)

1,159,666

 

Cash and cash equivalents at beginning of year

 

1,586,376

 

426,710

 

Cash and cash equivalents at end of year

 

841,204

 

1,586,376

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Company Cash Flow Statement

 

 

For the year ended 30 June 2011

 

 

 

2011

 

2010

 

 

 

£

 

£

 

Net cash used in operating activities

 

(395,785)

 

(737,485

)

Investing activities

 

 

 

 

 

Interest received

 

7,579

 

3,089

 

Acquisition of subsidiary, net of cash acquired

 

-

 

(1

)

Net cash generated from investing activities

 

7,579

 

3,088

 

Financing activities

 

 

 

 

 

Proceeds on issue of shares

 

-

 

1,553,270

 

Expenses paid in connection with share issues

 

-

 

(47,775

)

Net cash generated from financing activities

 

-

 

1,505,495

 

Net (decrease)/increase in cash and cash equivalents

 

(388,206)

 

771,098

 

Cash and cash equivalents at beginning of year

 

859,378

 

88,280

 

Cash and cash equivalents at end of year

 

471,172

 

859,378

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes to the Financial Statements

 

 

For the year ended 30 June 2011

 

1. Accounting policies

 

The principal accounting policies are summarised below. They have all been applied consistently throughout the period covered by these financial statements.

 

Reporting entity

 

Arcontech Group PLC ("the Company") is a company incorporated in the United Kingdom. The consolidated financial statements incorporate the financial statements of the Company and its subsidiaries (together referred to as "the Group").

 

Basis of preparation

 

These financial statements havebeen prepared in accordance with International Financial Reporting Standards ("IFRS") endorsed by the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

On the basis of current projections, confidence of future profitability and cash balances held the Directors have adopted the going concern basis in the preparation of the financial statements.

 

The financial statements have been prepared under the historical cost convention.

 

 

2. Revenue

 

An analysis of the Group's revenue is as follows:

 

 

 

2011£

 

2010£

 

 

 

 

 

 

 

Financial information service, advertising and sponsorship, software development and consultancy

 

1,287,409

 

1,068,776

 

All of the Group's revenue relates to continuing activities.

 

 

3. Operating loss for the year is stated after charging:

 

 

 

2011£

 

2010£

 

Depreciation of plant and equipment

 

16,893

 

18,868

 

Loss on disposal of fixed assets

 

3,091

 

-

 

Staff costs (see note 7)

 

1,473,442

 

1,453,848

 

Operating lease rentals - land and buildings (see note 21)

 

73,075

 

55,300

 

Research and development

 

812,559

 

636,386

 

 

4. Loss per share

 

 

 

2011

 

2010

 

 

 

£

 

£

 

Earnings

 

 

 

 

 

Earnings for the purpose of basic and diluted earnings per share being net loss attributable to equity shareholders

 

(672,038

)

(913,073

)

 

 

(672,038

)

(913,073

)

 

 

No.

 

No.

 

Number of shares

 

 

 

 

 

Weighted average number of ordinary shares for the purpose of basic earnings per share

 

1,531,314,870

 

1,335,592,398

 

Number of dilutive shares under option

 

-

 

-

 

Weighted average number of ordinary shares for the purposes of dilutive earnings per share

 

1,531,314,870

 

1,335,592,398

 

 

The calculation of diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, all of which arise from share options.  A calculation is done to determine the number of shares that could have been acquired at fair value, based upon the monetary value ofthe subscription rights attached to outstanding share options. Share options are anti-dilutive and are therefore not included above.

 

5. Dividends

 

There were no dividends paid or proposed during the period (2010: £nil).

 

 

 

6. Post balance sheet events

 

There were no events since the balance sheet date, which materially affect the position of the Group.

 

 

7. Annual General Meeting

 

The annual general meeting of the Company will be held at the Company's offices, 8th Floor, Finsbury Tower, 103-105 Bunhill Row, London EC1Y 8LZ on 18 October 2011 at 10 a.m.

 

8, Copies of this Statement

 

Copies of the Annual Report & Accounts will be sent to shareholders shortly and are available from the Company Secretary at the Company's registered office at 8th Floor Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8LZ or from the Company's website at www.arcontech.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UGUAPBUPGGGB
Date   Source Headline
21st Feb 20247:00 amRNSInterim Results
27th Oct 20237:00 amRNSNew Client Win
25th Oct 20231:42 pmRNSResult of AGM
3rd Oct 20235:40 pmRNSPosting of Annual Report & Notice of AGM
5th Sep 20237:00 amRNSFinal Results
24th Jul 20237:00 amRNSTrading Update and Notice of Results
10th May 20237:00 amRNSAppointment of consultant in Singapore
6th Apr 202311:45 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector Retirement
27th Feb 20237:00 amRNSInterim Results
26th Oct 20223:15 pmRNSBoard Appointment
21st Oct 20227:00 amRNSGrant of Options
17th Oct 20222:41 pmRNSResult of AGM
17th Oct 20222:41 pmRNSResult of AGM
23rd Sep 20224:30 pmRNSPosting of Annual Report & Notice of AGM
12th Sep 20227:00 amRNSFinal Results
30th Aug 20227:00 amRNSNotice of Results
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSInterim Results
17th Jan 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20219:06 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSTrading Update
15th Oct 20215:32 pmRNSDirector/PDMR Shareholding
12th Oct 20215:00 pmRNSGrant of Options
11th Oct 20217:00 amRNSHolding(s) in Company
1st Oct 20213:30 pmRNSResult of AGM
8th Sep 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Sep 20217:00 amRNSExercise of Options
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Shareholding
1st Sep 20214:41 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSNotice of Results
12th Mar 202112:16 pmRNSHolding(s) in Company
23rd Feb 20217:00 amRNSInterim Results
22nd Jan 20214:30 pmRNSIssue of Equity
16th Oct 20207:00 amRNSAgreement to upgrade longstanding Tier 1 Client
5th Oct 20203:03 pmRNSGrant of Options
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNew client win to contribute data to Factset
29th Sep 202010:53 amRNSResult of AGM
10th Sep 20207:00 amRNSIssue of Equity & PDMR Shareholding
8th Sep 20207:00 amRNSPosting of Annual Report & Notice of AGM
2nd Sep 20207:00 amRNSFinal Results
27th Aug 20201:59 pmRNSNotice of Results
20th Jul 20207:00 amRNSBoard appointment
15th Jul 20207:00 amRNSTrading Update / Notice of Results
1st Jun 20207:00 amRNSDirectorate change & Appointment of CoSec

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.